 | • レポートコード：GIR-105X19213 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ソフォスブビル/レジパスビル配合薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ソフォスブビル/レジパスビル配合薬の種類別市場規模（ボトル包装、フィルムコーティング包装）、用途別市場規模（C型肝炎ウイルス（HCV）遺伝子型1、C型肝炎ウイルス（HCV）遺伝子型3、C型肝炎ウイルス（HCV）遺伝子型4、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ソフォスブビル/レジパスビル配合薬の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Gilead Sciences、Natco Ltd、Zydus Cadila、Hetero Drugs、Dr Reddy's Laboratories、Sun Pharmaceutical Industries、Cipla、Abbott、Biocon、Torrent Pharmaceuticals、Lupin Ltd ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：ボトル包装、フィルムコーティング包装 ・用途別分析2016年-2026年：C型肝炎ウイルス（HCV）遺伝子型1、C型肝炎ウイルス（HCV）遺伝子型3、C型肝炎ウイルス（HCV）遺伝子型4、その他 ・ソフォスブビル/レジパスビル配合薬の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ソフォスブビル/レジパスビル配合薬のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ソフォスブビル/レジパスビル配合薬のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ソフォスブビル/レジパスビル配合薬の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ソフォスブビル/レジパスビル配合薬の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Sofosbuvir/Ledipasvir Compound Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Sofosbuvir/Ledipasvir Compound Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Sofosbuvir/Ledipasvir Compound Drugs market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Sofosbuvir/Ledipasvir Compound Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Bottled Packaging
Film Coated Packaging
Market segment by Application can be divided into
Hepatitis C Virus (HCV) Genotype 1
Hepatitis C Virus (HCV) Genotype 3
Hepatitis C Virus (HCV) Genotype 4
Other
The key market players for global Sofosbuvir/Ledipasvir Compound Drugs market are listed below:
Gilead Sciences
Natco Ltd
Zydus Cadila
Hetero Drugs
Dr Reddy’s Laboratories
Sun Pharmaceutical Industries
Cipla
Abbott
Biocon
Torrent Pharmaceuticals
Lupin Ltd
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Sofosbuvir/Ledipasvir Compound Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Bottled Packaging
1.2.3 Film Coated Packaging
1.3 Market Analysis by Application
1.3.1 Overview: Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hepatitis C Virus (HCV) Genotype 1
1.3.3 Hepatitis C Virus (HCV) Genotype 3
1.3.4 Hepatitis C Virus (HCV) Genotype 4
1.3.5 Other
1.4 Global Sofosbuvir/Ledipasvir Compound Drugs Market Size & Forecast
1.4.1 Global Sofosbuvir/Ledipasvir Compound Drugs Sales in Value (2016-2026))
1.4.2 Global Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume (2016-2026)
1.4.3 Global Sofosbuvir/Ledipasvir Compound Drugs Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Sofosbuvir/Ledipasvir Compound Drugs Production Capacity Analysis
1.5.1 Global Sofosbuvir/Ledipasvir Compound Drugs Total Production Capacity (2016-2026)
1.5.2 Global Sofosbuvir/Ledipasvir Compound Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Sofosbuvir/Ledipasvir Compound Drugs Market Drivers
1.6.2 Sofosbuvir/Ledipasvir Compound Drugs Market Restraints
1.6.3 Sofosbuvir/Ledipasvir Compound Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Gilead Sciences
2.1.1 Gilead Sciences Details
2.1.2 Gilead Sciences Major Business
2.1.3 Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Product and Services
2.1.4 Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Natco Ltd
2.2.1 Natco Ltd Details
2.2.2 Natco Ltd Major Business
2.2.3 Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Product and Services
2.2.4 Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Zydus Cadila
2.3.1 Zydus Cadila Details
2.3.2 Zydus Cadila Major Business
2.3.3 Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Product and Services
2.3.4 Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Hetero Drugs
2.4.1 Hetero Drugs Details
2.4.2 Hetero Drugs Major Business
2.4.3 Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Product and Services
2.4.4 Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Dr Reddy’s Laboratories
2.5.1 Dr Reddy’s Laboratories Details
2.5.2 Dr Reddy’s Laboratories Major Business
2.5.3 Dr Reddy’s Laboratories Sofosbuvir/Ledipasvir Compound Drugs Product and Services
2.5.4 Dr Reddy’s Laboratories Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Sun Pharmaceutical Industries
2.6.1 Sun Pharmaceutical Industries Details
2.6.2 Sun Pharmaceutical Industries Major Business
2.6.3 Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Product and Services
2.6.4 Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business
2.7.3 Cipla Sofosbuvir/Ledipasvir Compound Drugs Product and Services
2.7.4 Cipla Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Abbott
2.8.1 Abbott Details
2.8.2 Abbott Major Business
2.8.3 Abbott Sofosbuvir/Ledipasvir Compound Drugs Product and Services
2.8.4 Abbott Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Biocon
2.9.1 Biocon Details
2.9.2 Biocon Major Business
2.9.3 Biocon Sofosbuvir/Ledipasvir Compound Drugs Product and Services
2.9.4 Biocon Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Torrent Pharmaceuticals
2.10.1 Torrent Pharmaceuticals Details
2.10.2 Torrent Pharmaceuticals Major Business
2.10.3 Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Product and Services
2.10.4 Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Lupin Ltd
2.11.1 Lupin Ltd Details
2.11.2 Lupin Ltd Major Business
2.11.3 Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Product and Services
2.11.4 Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Sofosbuvir/Ledipasvir Compound Drugs Sales by Manufacturer
3.1 Global Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Sofosbuvir/Ledipasvir Compound Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Sofosbuvir/Ledipasvir Compound Drugs Manufacturer Market Share
3.4.2 Top 6 Sofosbuvir/Ledipasvir Compound Drugs Manufacturer Market Share
3.5 Global Sofosbuvir/Ledipasvir Compound Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Sofosbuvir/Ledipasvir Compound Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Sofosbuvir/Ledipasvir Compound Drugs Market Size by Region
4.1.1 Global Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2016-2026)
4.2 North America Sofosbuvir/Ledipasvir Compound Drugs Revenue (2016-2026)
4.3 Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue (2016-2026)
4.4 Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue (2016-2026)
4.5 South America Sofosbuvir/Ledipasvir Compound Drugs Revenue (2016-2026)
4.6 Middle East and Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Type (2016-2026)
5.2 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2016-2026)
5.3 Global Sofosbuvir/Ledipasvir Compound Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Application (2016-2026)
6.2 Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2016-2026)
6.3 Global Sofosbuvir/Ledipasvir Compound Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2016-2026)
7.2 North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2016-2026)
7.3 North America Sofosbuvir/Ledipasvir Compound Drugs Market Size by Country
7.3.1 North America Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2016-2026)
8.2 Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2016-2026)
8.3 Europe Sofosbuvir/Ledipasvir Compound Drugs Market Size by Country
8.3.1 Europe Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Market Size by Region
9.3.1 Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2016-2026)
10.2 South America Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2016-2026)
10.3 South America Sofosbuvir/Ledipasvir Compound Drugs Market Size by Country
10.3.1 South America Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Market Size by Country
11.3.1 Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Sofosbuvir/Ledipasvir Compound Drugs Typical Distributors
12.3 Sofosbuvir/Ledipasvir Compound Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Gilead Sciences Basic Information, Manufacturing Base and Competitors
Table 4. Gilead Sciences Major Business
Table 5. Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Product and Services
Table 6. Gilead Sciences Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Natco Ltd Basic Information, Manufacturing Base and Competitors
Table 8. Natco Ltd Major Business
Table 9. Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Product and Services
Table 10. Natco Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 12. Zydus Cadila Major Business
Table 13. Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Product and Services
Table 14. Zydus Cadila Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table 16. Hetero Drugs Major Business
Table 17. Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Product and Services
Table 18. Hetero Drugs Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Dr Reddy's Laboratories Major Business
Table 21. Dr Reddy's Laboratories Sofosbuvir/Ledipasvir Compound Drugs Product and Services
Table 22. Dr Reddy's Laboratories Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 24. Sun Pharmaceutical Industries Major Business
Table 25. Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Product and Services
Table 26. Sun Pharmaceutical Industries Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Cipla Basic Information, Manufacturing Base and Competitors
Table 28. Cipla Major Business
Table 29. Cipla Sofosbuvir/Ledipasvir Compound Drugs Product and Services
Table 30. Cipla Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Abbott Basic Information, Manufacturing Base and Competitors
Table 32. Abbott Major Business
Table 33. Abbott Sofosbuvir/Ledipasvir Compound Drugs Product and Services
Table 34. Abbott Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Biocon Basic Information, Manufacturing Base and Competitors
Table 36. Biocon Major Business
Table 37. Biocon Sofosbuvir/Ledipasvir Compound Drugs Product and Services
Table 38. Biocon Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Torrent Pharmaceuticals Major Business
Table 41. Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Product and Services
Table 42. Torrent Pharmaceuticals Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Lupin Ltd Basic Information, Manufacturing Base and Competitors
Table 44. Lupin Ltd Major Business
Table 45. Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Product and Services
Table 46. Lupin Ltd Sofosbuvir/Ledipasvir Compound Drugs Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 48. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Sofosbuvir/Ledipasvir Compound Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Sofosbuvir/Ledipasvir Compound Drugs Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 51. Head Office and Sofosbuvir/Ledipasvir Compound Drugs Production Site of Key Manufacturer
Table 52. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Region (2016-2021e) & (K Pcs)
Table 53. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Region (2021-2026) & (K Pcs)
Table 54. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 57. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2021-2026) & (K Pcs)
Table 58. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Sofosbuvir/Ledipasvir Compound Drugs Price by Type (2016-2021e) & (USD/Pcs)
Table 61. Global Sofosbuvir/Ledipasvir Compound Drugs Price by Type (2021-2026) & (USD/Pcs)
Table 62. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 63. Global Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2021-2026) & (K Pcs)
Table 64. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Sofosbuvir/Ledipasvir Compound Drugs Price by Application (2016-2021e) & (USD/Pcs)
Table 67. Global Sofosbuvir/Ledipasvir Compound Drugs Price by Application (2021-2026) & (USD/Pcs)
Table 68. North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 69. North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2021-2026) & (K Pcs)
Table 70. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 73. North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2021-2026) & (K Pcs)
Table 74. North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 75. North America Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2021-2026) & (K Pcs)
Table 76. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 77. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2021-2026) & (K Pcs)
Table 78. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 81. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2021-2026) & (K Pcs)
Table 82. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 83. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2021-2026) & (K Pcs)
Table 84. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Region (2016-2021e) & (K Pcs)
Table 85. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Region (2021-2026) & (K Pcs)
Table 86. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 89. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2021-2026) & (K Pcs)
Table 90. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 91. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2021-2026) & (K Pcs)
Table 92. South America Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 93. South America Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2021-2026) & (K Pcs)
Table 94. South America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 97. South America Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2021-2026) & (K Pcs)
Table 98. South America Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 99. South America Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2021-2026) & (K Pcs)
Table 100. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2016-2021e) & (K Pcs)
Table 101. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Country (2021-2026) & (K Pcs)
Table 102. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2016-2021e) & (K Pcs)
Table 105. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Type (2021-2026) & (K Pcs)
Table 106. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2016-2021e) & (K Pcs)
Table 107. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales by Application (2021-2026) & (K Pcs)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Sofosbuvir/Ledipasvir Compound Drugs Typical Distributors
Table 111. Sofosbuvir/Ledipasvir Compound Drugs Typical Customers
List of Figures
Figure 1. Sofosbuvir/Ledipasvir Compound Drugs Picture
Figure 2. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type in 2020
Figure 3. Bottled Packaging
Figure 4. Film Coated Packaging
Figure 5. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application in 2020
Figure 6. Hepatitis C Virus (HCV) Genotype 1
Figure 7. Hepatitis C Virus (HCV) Genotype 3
Figure 8. Hepatitis C Virus (HCV) Genotype 4
Figure 9. Other
Figure 10. Global Sofosbuvir/Ledipasvir Compound Drugs Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Sofosbuvir/Ledipasvir Compound Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Sofosbuvir/Ledipasvir Compound Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Sofosbuvir/Ledipasvir Compound Drugs Sales (2016-2026) & (K Pcs)
Figure 32. Global Sofosbuvir/Ledipasvir Compound Drugs Production Capacity (2016-2026) & (K Pcs)
Figure 33. Global Sofosbuvir/Ledipasvir Compound Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Sofosbuvir/Ledipasvir Compound Drugs Market Drivers
Figure 35. Sofosbuvir/Ledipasvir Compound Drugs Market Restraints
Figure 36. Sofosbuvir/Ledipasvir Compound Drugs Market Trends
Figure 37. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Manufacturer in 2020
Figure 38. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Manufacturer in 2020
Figure 39. Sofosbuvir/Ledipasvir Compound Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Sofosbuvir/Ledipasvir Compound Drugs Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Sofosbuvir/Ledipasvir Compound Drugs Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Region (2016-2026)
Figure 43. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Region (2016-2026)
Figure 44. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue (2016-2026) & (USD Million)
Figure 45. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue (2016-2026) & (USD Million)
Figure 47. South America Sofosbuvir/Ledipasvir Compound Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type (2016-2026)
Figure 50. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Type (2016-2026)
Figure 51. Global Sofosbuvir/Ledipasvir Compound Drugs Price by Type (2016-2026) & (USD/Pcs)
Figure 52. Global Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2016-2026)
Figure 53. Global Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Application (2016-2026)
Figure 54. Global Sofosbuvir/Ledipasvir Compound Drugs Price by Application (2016-2026) & (USD/Pcs)
Figure 55. North America Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Country (2016-2026)
Figure 56. North America Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Country (2016-2026)
Figure 57. North America Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type (2016-2026)
Figure 58. North America Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2016-2026)
Figure 59. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Country (2016-2026)
Figure 60. Europe Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Country (2016-2026)
Figure 61. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type (2016-2026)
Figure 62. Europe Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2016-2026)
Figure 67. South America Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Country (2016-2026)
Figure 68. South America Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Country (2016-2026)
Figure 69. South America Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type (2016-2026)
Figure 70. South America Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Sofosbuvir/Ledipasvir Compound Drugs Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のテノホビル/アラフェナミド複合薬市場 2021：企業別、地域別、種類・用途別 The Tenofovir/Alafenamide Compound Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- 世界のレジパスビル市場 2021：企業別、地域別、種類・用途別 The Ledipasvir market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent …
- C型肝炎ウイルスと治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma. Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma Scope of the Report: This report studies the Hepatitis C Virus And Therapeutics market status and…
- 世界のエファビレンツ/ラミブジン/テノホビル複合薬市場 2021：企業別、地域別、種類・用途別 The Efavirenz/Lamivudine/Tenofovir Compound Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- Ｃ型肝炎薬の世界市場2018-2025 Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc.Hepatitis is caused by a variety of factors both microbial and non-microbial. However hepat…